A team of researchers has introduced a bioadhesive hydrogel-coupled, miniaturized ultrasound transducer system for long-term neuromodulation, outlined in a publication in Nature Communications.
This technology targets deep brain regions with non-invasive ultrasound-based neuromodulation, addressing limitations of traditional methods such as poor skin adhesion and bulky designs.
The system integrates a biomimetic hydrogel interface for comfortable and flexible skin adhesion, promoting continuous, long-term therapy application.
The ultrathin ultrasound transducer ensures efficient acoustic energy transmission for stimulating neurons beneath the skin.
The bioadhesive hydrogel used is biocompatible, breathable, and maintains strong adhesion even during sweating or movement, allowing for uninterrupted therapy sessions.
The device is designed to conform closely to the body's contours, minimizing detachment and ensuring optimal performance.
Optimized for low power consumption, the system's electrical and acoustic design parameters enable continuous operation without frequent battery changes.
Customizable neuromodulation protocols offer high spatial resolution for targeting specific neuronal populations, catering to diverse clinical indications.
Thorough biocompatibility and safety evaluations in animal models demonstrate the system's compliance with regulatory thresholds, supporting future human trials.
The interdisciplinary collaboration behind this technology bridges materials science, electrical engineering, neurobiology, and clinical medicine, presenting a holistic approach to neuromodulation.